Diabetes Mellitus, Type 2  >>  BIAsp 30 (biphasic insulin aspart 30/70 biosimilar)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

31 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk
NCT01542060: Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus

Completed
N/A
298
RoW
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
12/04
12/04
NCT01536652: Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes

Completed
N/A
4994
Europe
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
11/06
11/06
NCT01536600: Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes

Completed
N/A
33010
RoW
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
12/06
12/06
NCT01536639: Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes

Completed
N/A
454
Europe
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
12/06
12/06
NCT01542424: An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus

Completed
N/A
1889
RoW
biphasic insulin aspart 30, insulin detemir
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
12/06
12/06
NCT01536613: Post Marketing Surveillance Study of Biphasic Insulin Aspart 30

Completed
N/A
5346
RoW
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
02/07
02/07
NCT01548235: Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment

Completed
N/A
423
Europe
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
04/07
04/07
NCT01536626: Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands

Completed
N/A
211
Europe
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
04/07
04/07
NCT01565733: Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes

Completed
N/A
2223
Europe
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
07/07
07/07
NCT00715663: Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes

Completed
N/A
1584
RoW
biphasic insulin aspart 30, NovoMix® 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2, Delivery Systems
12/07
12/07
Start, NCT01486875: Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes

Completed
N/A
1155
Europe
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
01/08
01/08
NCT00665093: Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Completed
N/A
1569
RoW
biphasic insulin aspart 30, NovoMix® 30, BIASP, insulin detemir
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
01/08
01/08
NCT00657319: Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins

Completed
N/A
3495
Europe
biphasic insulin aspart 30, NovoMix® 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
03/08
04/08
Start, NCT00696995: An Observational Study of Type 2 Diabetes in Patients ing on NovoMix® 30 Treatment

Completed
N/A
509
Europe
biphasic insulin aspart 30, NovoMix® 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
09/08
09/08
NCT00671008: Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Completed
N/A
400
RoW
biphasic insulin aspart 30, NovoMix® 30, insulin detemir
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
09/08
09/08
IMPROVEâ„¢, NCT00659282: Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes

Completed
N/A
57610
Japan, Canada, Europe, RoW
biphasic insulin aspart, BIASP, NovoMix 30, NovoLog Mix 70/30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
11/08
11/08
NCT00675493: Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30

Completed
N/A
942
Europe
biphasic insulin aspart 30, NovoMix® 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
01/09
01/09
IMPROVE Life, NCT00696163: Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes

Completed
N/A
24975
RoW
biphasic insulin aspart 30, NovoMix® 30, BIAsp30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
03/09
03/09
NCT00709683: Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®

Completed
N/A
216
RoW
biphasic insulin aspart 30, NovoMix® 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
05/09
05/09
NCT00698269: An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment

Completed
N/A
5926
RoW
insulin detemir, Levemir®, biphasic insulin aspart 30, insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
08/09
08/09
SAFE, NCT00789711: An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes

Completed
N/A
3131
RoW
biphasic insulin aspart 30, NovoMix® 30, BIASP, insulin detemir
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
08/09
08/09
EFFECTIVE, NCT00699179: Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

Completed
N/A
2308
RoW
biphasic insulin aspart 30, NovoMix® 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
09/09
09/09
NCT00670722: Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

Completed
N/A
6500
Europe
insulin aspart, NovoRapid®, insulin detemir, biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
12/09
12/09
UPGRADE, NCT00737776: Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes

Completed
N/A
1068
RoW
biphasic insulin aspart 30, NovoMix® 30, NovoLog® Mix 70/30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
01/10
01/10
NCT00834262: Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

Completed
N/A
339
RoW
biphasic insulin aspart 30, NovoMix® 30, biphasic insulin aspart 50, biphasic insulin aspart 70
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
02/10
02/10
COMMIT, NCT00676741: Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

Completed
N/A
3809
Europe
insulin aspart, NovoRapid®, biphasic insulin aspart 30, insulin detemir
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
05/10
05/10
NCT00771680: Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes

Completed
N/A
10408
RoW
insulin detemir, biphasic insulin aspart 30, insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
07/10
07/10
NCT00729898: Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes

Completed
N/A
243
Europe
biphasic insulin aspart 30, NovoMix® 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
09/10
09/10
NCT00842894: Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia

Completed
N/A
3421
RoW
insulin detemir, NN304, Levemir®, biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
10/10
10/10
Mix2Mix, NCT00775736: Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin

Completed
N/A
611
Europe
biphasic insulin aspart 30, BIAsp, biphasic insulin aspart 50, biphasic insulin aspart 70
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
01/11
01/11
A1chieve, NCT00869908: Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

Checkmark
Feb 2014 - Feb 2014: 
Checkmark
Feb 2014 - Feb 2014: 
Checkmark
More
Completed
N/A
66726
RoW
insulin aspart, NovoRapid®, ANA, insulin detemir, biphasic insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
03/11
03/11

Download Options